Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

Presentation ACC 2023

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

Presenter: Annapoorna S. Kini

March 06, 2023

Presentation AHA 2022

Comparison of a Precision Care Strategy With Usual Testing To Guide Management Of Stable Patients With Suspected Coronary Artery Disease

Presenter: Pamela S. Douglas

November 07, 2022

Presentation

Dobutamine Stress Echo Ischemia a Predictor of PCI Efficacy in Stable CAD

November 14, 2019

Presentation ESC 2019

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Presenter: Deepak Bhatt

September 01, 2019

Presentation OPCI 2019

Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD

Presenter: William F. Fearon

March 09, 2019

Presentation Intravascular Coronary Imaging and Physiology 2018

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

Presenter: Allen Jeremias

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

PCI should not be first line therapy for patients with stable CAD – Lessons learned from ORBITA

Presenter: Rasha Al-Lamee

May 05, 2018

Presentation iASSESS 2017

Stable Angina: PCI vs CABG vs OMT

Presenter: Robert T. Pyo

August 30, 2017

Presentation ESC 2017

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Presenter: John Eikelboom

August 27, 2017

Presentation

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

April 25, 2017

Presentation

Outcomes Among Older Stable Angina Patients Prescribed Beta-Blockers After PCI

Presenter: AA. Motivala

August 17, 2016

Presentation

Impact of Diabetes and Metabolic Syndrome on Acute and Chronic On-Clopidogrel Platelet Reactivity in Patients with Stable CAD Receiving DES

Presenter: Laurent Feldman

October 06, 2014

Presentation

Incidence, Source, Determinants, and Prognostic Impact of Major Bleeding in Stable CAD

Presenter: M. Hanon

September 30, 2014

Presentation TCT 2014

Pro: Follow the Data - and Save the Money!

Presenter: Adrian P. Banning, Rod H. Stables

September 16, 2014

Presentation TCT 2014

The Case for Selective Use of Prasugrel and Ticagrelor in PCI Patients with Stable CAD

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Matthew J. Price

September 14, 2014

Presentation TCT 2014

Time to Move to 3-6 Months Even in ACS!

Presenter: Marco Valgimigli

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Rod H. Stables

September 14, 2014

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

Presentation

DAPT in Stable CAD in Modern Practice: Prevalence, Correlates, and Impact on Prognosis

Presenter: Gilles Lemesle

July 02, 2014

Presentation

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Presenter: Sripal Bangalore

April 22, 2014

Advertisement

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

Comparison of a Precision Care Strategy With Usual Testing To Guide Management Of Stable Patients With Suspected Coronary Artery Disease

Dobutamine Stress Echo Ischemia a Predictor of PCI Efficacy in Stable CAD

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

PCI should not be first line therapy for patients with stable CAD – Lessons learned from ORBITA

Stable Angina: PCI vs CABG vs OMT

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

Outcomes Among Older Stable Angina Patients Prescribed Beta-Blockers After PCI

Impact of Diabetes and Metabolic Syndrome on Acute and Chronic On-Clopidogrel Platelet Reactivity in Patients with Stable CAD Receiving DES

Incidence, Source, Determinants, and Prognostic Impact of Major Bleeding in Stable CAD

Pro: Follow the Data - and Save the Money!

The Case for Selective Use of Prasugrel and Ticagrelor in PCI Patients with Stable CAD

Time to Move to 3-6 Months Even in ACS!

The Data Strongly Support Heparin!

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

DAPT in Stable CAD in Modern Practice: Prevalence, Correlates, and Impact on Prognosis

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content